Should testing be initiated prior to amoxicillin challenge in children?
Corresponding Author
Elissa M. Abrams
Section of Allergy and Clinical Immunology, Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba, Canada
Correspondence
Elissa M. Abrams, FE125-685 William Avenue, Winnipeg, MB R3E 0Z2, Canada.
Email: [email protected]
Search for more papers by this authorMoshe Ben-Shoshan
Division of Allergy and Clinical Immunology, Department of Pediatrics, McGill University, Montreal, Quebec, Canada
Search for more papers by this authorCorresponding Author
Elissa M. Abrams
Section of Allergy and Clinical Immunology, Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba, Canada
Correspondence
Elissa M. Abrams, FE125-685 William Avenue, Winnipeg, MB R3E 0Z2, Canada.
Email: [email protected]
Search for more papers by this authorMoshe Ben-Shoshan
Division of Allergy and Clinical Immunology, Department of Pediatrics, McGill University, Montreal, Quebec, Canada
Search for more papers by this authorAbstract
Amoxicillin is the most common antibiotic prescribed in children with increasing use over time. While up to 10% of children are labelled as amoxicillin allergic, most children can tolerate amoxicillin after allergy evaluation. It is well documented that the label of amoxicillin allergy in children is associated with adverse health outcomes such as antibiotic-resistant infections. However, it remains controversial how best to assess children for amoxicillin allergy. While in general it is recommended that skin testing be done prior to drug provocation test in the evaluation of amoxicillin allergy, there is increasing evidence that drug provocation testing could be done in lower risk children without skin testing prior. The goal of this article as a narrative review is to review the strengths and limitations of skin testing prior to drug provocation test in children who have a history of either immediate or non-immediate, reactions to amoxicillin.
CONFLICTS OF INTEREST
The authors declare no conflict of interest.
REFERENCES
- 1Blanca M. Allergic reactions to penicillins. A changing world? Allergy. 1995; 50: 777-782.
- 2Ferech M, Coenen S, Malhotra-Kumar S, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother. 2006; 58: 401-407.
- 3 CDC: Antibiotic prescribing and use in doctor's offices. https://www.cdc.gov/antibiotic-use/index.html
- 4Rebelo Gomes E, Fonseca J, Araujo L, Demoly P. Drug allergy claims in children: From self-reporting to confirmed diagnosis. Clin Exp Allergy. 2008; 38: 191-198.
- 5Ponvert C, Perrin Y, Bados-Albiero A, et al. Allergy to betalactam antibiotics in children: Results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011; 22: 411-418.
- 6Krishna MT, Huissoon AP, Li M, et al. Enhancing antibiotic stewardship by tackling “spurious” penicillin allergy. Clin Exp Allergy. 2017; 47: 1362-1373.
- 7Abrams EM, Wakeman A, Gerstner TV, Warrington RJ, Singer AG. Prevalence of beta-lactam allergy: A retrospective chart review of drug allergy assessment in a predominantly pediatric population. Allergy Asthma Clin Immunol. 2016; 12: 59.
- 8Liu T-H, Lin Y-R, Yang K-C, Chou C-C, Chang Y-J, Wu H-P. First attack of acute urticaria in pediatric emergency department. Pediatr Neonatol. 2008; 49: 58-64.
- 9Mill C, Primeau M-N, Medoff E, et al. Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children. JAMA Pediatr. 2016; 170: 1-8.
- 10Mirakian R, Leech SC, Krishna MT, et al. Management of allergy to penicillins and other beta-lactams. Clin Exp Allergy. 2015; 45: 300-327.
- 11Khan DA, Solensky R. Drug allergy. J Allergy Clin Immunol. 2010; 125: 126-138.
- 12Blanca M, Torres MJ, García JJ, et al. Natural evolution of skin test sensitivity in patients allergic to β-lactam antibiotics. J Allergy Clin Immunol. 1999; 103: 918-924.
- 13Abrams EM, Atkinson AR, Wong T, Ben-Shoshan M. The importance of delabeling beta-lactam allergy in children. J Pediatr. 2018; 204: 291-297.e1.
- 14Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365: 579-587.
- 15Blumenthal KG, Lu N, Zhang Y, Li Y, Walensky RP, Choi HK. Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ. 2018; 361: k2400.
- 16 Centers for Disease Control and Prevention. https://www.cdc.gov/drugresistance/index.html
- 17Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: A cohort study. J Allergy Clin Immunol. 2014; 133: 790-796.
- 18Shaikh N, Dando EE, Dunleavy ML, et al. A cost-utility analysis of 5 strategies for the management of acute otitis media in children. J Pediatr. 2017; 189: 54-60.e3.
- 19Chen JR, Tarver SA, Alvarez KS, Tran T. A proactive approach to penicillin allergy testing in hospitalized patients. J Allergy Clin Immunol Pract. 2017; 5(3): 686-693.
- 20Macy E, Shu Y-H. The effect of penicillin allergy testing on future health care utilization: a matched Cohort Study. J Allergy Clin Immunol Pract. 2017; 5: 705-710.
- 21Rimawi RH, Cook PP, Gooch M, et al. The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med. 2013; 8: 341-345.
- 22Lang DM, Castells MC, Khan DA, Macy EM, Murphy AW. Penicillin allergy testing should be performed routinely in patients with self-reported penicillin allergy. J Allergy Clin Immunol Pract. 2017; 5: 333-334.
- 23NoChoosing Wisely. American Academy of Allergy, Asthma and Immunology: Ten Things Physicians and Patients Should Question. https://www.choosingwisely.org/societies/american-academy-of-allergy-asthma-immunology/
- 24Vaisman A, McCready J, Hicks S, Powis J. Optimizing preoperative prophylaxis in patients with reported beta-lactam allergy: a novel extension of antimicrobial stewardship. J Antimicrob Chemother. 2017; 72: 2657-2660.
- 25Park M, Markus P, Matesic D, Li J. Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol. 2006; 97: 681-687.
- 26Krey SC, Waise J, Skrupky LP. Confronting the challenge of beta-lactam allergies: a quasi-experimental study assessing impact of pharmacy-led interventions. J Pharm Pract. 2019; 32(2): 139-146.
- 27Clark KE, Briand ME, Kapoor O, Pirasteh A. Impact of a standardized beta-lactam allergy questionnaire on aztreonam use. J Pharm Pract. 2018. 1: 897190018758557.
- 28King EA, Challa S, Curtin P, Bielory L. Penicillin skin testing in hospitalized patients with beta-lactam allergies: effect on antibiotic selection and cost. Ann Allergy Asthma Immunol. 2016; 117: 67-71.
- 29Blumenthal KG, Shenoy ES, Wolfson AR, et al. Addressing inpatient beta-lactam allergies: a multihospital implementation. J Allergy Clin Immunol Pract. 2017; 5 616-625.e7.
- 30Marwood J, Aguirrebarrena G, Kerr S, Welch SA, Rimmer J. De-labelling self-reported penicillin allergy within the emergency department through the use of skin tests and oral drug provocation testing. Emerg Med Australas. 2017; 29: 509-515.
- 31Of O, Tannert LK, Mortz CG, et al. Elective penicillin skin testing in a pediatric outpatient setting. Ann Allergy, Asthma Immunol. 2006; 97: 3-12.
- 32Weiss ME, Bernstein DI, Blessing-moore J, et al. Drug allergy: an updated practice parameter. Ann Allergy, Asthma Immunol. 2010; 105: 259-273.
- 33Fernandez TD, Mayorga C, Ariza A, Corzo JL, Torres MJ. Allergic reactions to antibiotics in children. Curr Opin Allergy Clin Immunol. 2014; 14: 278-285.
- 34Romano A, Caubet JC. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. J Allergy Clin Immunol Pract. 2014; 2(1): 3-12.
- 35 Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010; 105: 259-273.
- 36Macy E, Romano A, Khan D. Practical management of antibiotic hypersensitivity in 2017. J allergy Clin Immunol Pract. 2017; 5: 577-586.
- 37Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med. 1987; 107: 204-215.
- 38Bousquet PJ, Kvedariene V, Co-Minh H-B, et al. Clinical presentation and time course in hypersensitivity reactions to beta-lactams. Allergy. 2007; 62: 872-876.
- 39Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and management of penicillin allergy: a review. JAMA. 2019; 321: 188-199.
- 40Solensky R, Jacobs J, Lester M, et al. Penicillin allergy evaluation: A prospective, multicenter, open label evaluation of a comprehensive penicillin skin test kit. J allergy Clin Immunol Pract. 2019.[epub ahead of print].
- 41Vyles D, Chiu A, Simpson P, Nimmer M, Adams J, Brousseau DC. Parent-reported penicillin allergy symptoms in the Pediatric Emergency Department. Acad Pediatr. 2017; 17: 251-255.
- 42Ibáñez MD, Rodríguez del Río P, Lasa EM, et al. Prospective assessment of diagnostic tests for pediatric penicillin allergy: from clinical history to challenge tests. Ann Allergy Asthma Immunol. 2018; 121: 235-244.e3.
- 43Zhang T, Che D, Liu R, et al. Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2. Eur J Immunol. 2017; 47: 1949-1958.
- 44Pichler WJ. The p-i concept: pharmacological interaction of drugs with immune receptors. World Allergy Organ J. 2008; 1: 96-102.
- 45Macy E, Ngor EW. Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. J Allergy Clin Immunol Pract. 2013; 1: 258-263.
- 46Loong T-W. Understanding sensitivity and specificity with the right side of the brain. BMJ. 2003; 327: 716-719.
- 47Zambonino MA, Corzo JL, Muñoz C, et al. Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy Immunol. 2014; 25: 80-87.
- 48Chiriac AM, Vasconcelos M-J, Izquierdo L, Ferrando L, Nahas O, Demoly P. To challenge or not to challenge: literature data on the positive predictive value of skin tests to beta-lactams. J Allergy Clin Immunol Pract. 2019.
10.1016/j.jaip.2019.01.060 Google Scholar
- 49Vega JM, Blanca M, Garcia JJ, et al. Immediate allergic reactions to amoxicillin. Allergy. 1994; 49: 317-322.
- 50Sastre J, Quijano L-D, Novalbos A, et al. Clinical cross-reactivity between amoxicillin and cephadroxil in patients allergic to amoxicillin and with good tolerance of penicillin. Allergy. 1996; 51: 383-386.
- 51Herman R, Jick H. Cutaneous reaction rates to penicillins–oral versus parenteral. Cutis. 1979; 24: 232-234.
- 52Caubet J-C, Kaiser L, Lemaitre B, Fellay B, Gervaix A, Eigenmann PA. The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. J Allergy Clin Immunol. 2011; 127: 218-222.
- 53Co Minh H-B, Bousquet PJ, Fontaine C, Kvedariene V, Demoly P. Systemic reactions during skin tests with beta-lactams: a risk factor analysis. J Allergy Clin Immunol. 2006; 117: 466-468.
- 54Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge. J Pediatr. 1998; 132: 137-143.
- 55Ben-Shoshan M. Most children labeled as penicillin allergic are at low risk for true penicillin allergy. J Pediatr. 2017; 188: 308-311.
- 56Iammatteo M, Alvarez Arango S, Ferastraoaru D, et al. Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing. J Allergy Clin Immunol Pract. 2019; 7: 236-243.
- 57 International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet. 1991; 337: 1308-1310.
- 58Lee P, Shanson D. Results of a UK survey of fatal anaphylaxis after oral amoxicillin. J Antimicrob Chemother. 2007; 60: 1172-1173.
- 59Simons F. Anaphylaxis. J Allergy Clin Immunol. 2010; 125: S161-S181.
- 60Blumenthal KG, Huebner EM, Fu X, et al. Pathway for outpatient penicillin allergy evaluations. J Allergy Clin Immunol Pract. 2019.[epub ahead of print]
- 61Banks TA, Tucker M, Macy E. evaluating penicillin allergies without skin testing. Curr Allergy Asthma Rep. 2019; 19: 27.
- 62Torres MJ, Adkinson NF, Caubet J-C, et al. Controversies in drug allergy: beta-lactam hypersensitivity testing. J Allergy Clin Immunol Pract. 2019; 7: 40-45.
- 63Anterasian CM, Geng B. Penicillin skin testing in the management of penicillin allergy in an outpatient pediatric population. Allergy Asthma Proc. 2018; 39: 305-310.
- 64Barni S, Mori F, Sarti L, et al. Utility of skin testing in children with a history of non-immediate reactions to amoxicillin. Clin Exp Allergy. 2015; 45: 1472-1474.
- 65Padial A, Antunez C, Blanca-Lopez N, et al. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy. 2008; 38: 822-828.
- 66Caubet J-C, Frossard C, Fellay B, Eigenmann PA. Skin tests and in vitro allergy tests have a poor diagnostic value for benign skin rashes due to beta-lactams in children. Pediatr Allergy Immunol. 2015; 26: 80-82.
- 67Blanca-López N, Zapatero L, Alonso E, et al. Skin testing and drug provocation in the diagnosis of nonimmediate reactions to aminopenicillins in children. Allergy. 2009; 64: 229-233.
- 68Tonson la Tour A, Michelet M, Eigenmann PA, Caubet J-C, Caubet J-C. Natural history of benign nonimmediate allergy to beta-lactams in children: a prospective study in retreated patients after a positive and a negative provocation test. J Allergy Clin Immunol Pract. 2018; 6: 1321-1326.
- 69Trautmann A, Benoit S, Goebeler M, Stoevesandt J. “Treating Through” decision and follow-up in antibiotic therapy-associated exanthemas. J Allergy Clin Immunol Pract. 2017; 5: 1650-1656.
- 70Tatum AJ, Ditto AM, Patterson R. Severe serum sickness-like reaction to oral penicillin drugs: three case reports. Ann Allergy Asthma Immunol. 2001; 86: 330-334.
- 71Dodiuk-Gad RP, Laws PM, Shear NH. Epidemiology of severe drug hypersensitivity. Semin Cutan Med Surg. 2014; 33: 2-9.
- 72Phillips EJ, Bigliardi P, Bircher AJ, et al. Controversies in drug allergy: testing for delayed reactions. J Allergy Clin Immunol. 2019; 143: 66-73.
- 73Mori F, Cianferoni A, Barni S, Pucci N, Rossi ME, Novembre E. Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions. J Allergy Clin Immunol Pract. 2015; 3: 375-380.e1.
- 74Pichler WJ, Hausmann O. Classification of drug hypersensitivity into allergic, p-i, and Pseudo-Allergic Forms. Int Arch Allergy Immunol. 2016; 171: 166-179.
- 75Picard M, Paradis L, Nguyen M, Begin P, Paradis J, Des RA. Outpatient penicillin use after negative skin testing and drug challenge in a pediatric population. Allergy Asthma Proc. 2012; 33: 160-164.
- 76Warrington RJ, Burton R, Tsai E. The value of routine penicillin allergy skin testing in an outpatient population. Allergy Asthma Proc. 2003; 24: 199-202.